LNSR vs SRTS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LNSR exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.63, indicating negative shareholder equity. The company is suffering from catastrophic profitability metrics, including an ROE of -1069.41% and an operating margin of -116.03%. Despite a 'strong_buy' analyst consensus from a very small sample (2 analysts), the fundamental data shows declining revenue (-4.20% YoY) and a consistent failure to meet earnings estimates (0/4 beats in the last year). The technical trend is aggressively bearish, with a 51.6% price collapse in the last month alone.
SRTS exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY revenue decline of 62.20%. While the company maintains a strong liquidity position with a Current Ratio of 9.72 and negligible debt, these are offset by negative operating margins (-63.74%) and a consistent failure to meet earnings estimates. The recent short-term price appreciation contradicts the underlying financial decay and the bearish technical trend score of 0/100. Overall, the company is in a state of operational distress despite its clean balance sheet.
Compare Another Pair
Related Comparisons
LNSR vs SRTS: Head-to-Head Comparison
This page compares LENSAR, Inc. (LNSR) and Sensus Healthcare, Inc. (SRTS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.